Clinical Trial

A Study to Assess the Effect of Libifem® (VL-GF-01) on Fertility in Women With Diminished Ovarian Reserve

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 14, 2025 (before its estimated December 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
The present study is a randomized, double-blind, placebo-controlled, parallel clinical study. Approximately 156 participants will be screened, and considering a screening failure rate of 20%, not more than 124 participants will be randomized in a ratio of 1:1 to receive either Libifem® or placebo and will be assigned a unique randomization code. Each group will have not less than 50 completed participants after accounting for a dropout/withdrawal rate of 20%.
Trial Details
NCT Number NCT06826716
Lead Sponsor Vedic Lifesciences Pvt. Ltd.
Conditions Female Fertility
Enrollment 150 participants
Start Date 2025-02-10
Primary Completion 2025-12-05 (estimated)
Study Completion 2025-12-10 (estimated)
Updated on ClinicalTrials.gov 2025-02-14